Default: The Lancet HIV

ISSN:

Journal Home

Journal Guideline

The Lancet HIV Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet HIV is a journal indexed in SJR in Infectious Diseases and Immunology with an H index of 62. It has an SJR impact factor of 5,296 and it has a best quartile of Q1. It has an SJR impact factor of 5,296.

The Lancet HIV focuses its scope in these topics and keywords: inhibitors, disease, multicohort, life, national, northern, observational, prices, prospective, protease, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

The Lancet HIV

5,296

SJR Impact factor

62

H Index

148

Total Docs (Last Year)

547

Total Docs (3 years)

2801

Total Refs

2602

Total Cites (3 years)

229

Citable Docs (3 years)

5.08

Cites/Doc (2 years)

18.93

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


inhibitors, disease, multicohort, life, national, northern, observational, prices, prospective, protease, rates, reduce, responsecardiovascular, riskpopulism, studiesfirstline, study, switch, therapy, antiretroviral, england, balancewhat, benefitshiv, bictegravir, brazils, cardiovascular, cohort, contemporary, dad, defining, background, hiv, hivaids, hivassociated, incidence, integrase, international, ireland,

FAQS